Literature DB >> 25119068

Attention-deficit/hyperactivity disorder and risk for drug use disorder: a population-based follow-up and co-relative study.

J Sundquist1, H Ohlsson1, K Sundquist1, K S Kendler2.   

Abstract

BACKGROUND: Although the association between attention-deficit/hyperactivity disorder (ADHD) and drug use disorder (DUD) is well documented, it is unclear whether it is causal or results from familial confounding.
METHOD: In this study we included all 551 164 individuals born in Sweden between 1991 and 1995 and used linked data from multiple nationwide registries to identify those with ADHD prior to age 15 years (1.71%). We used Cox proportional hazards models to investigate the future risk for DUD as a function of an ADHD registration and then compared the results from the entire population with the results from a co-relative design. Using the Swedish Multi-Generation Register, we identified all full-sibling, half-sibling and first-cousin pairs discordant for ADHD.
RESULTS: In the population sample, ADHD had a substantially increased risk for future DUD with a hazard ratio (HR) of 3.34 after accounting for gender and parental education. Examining discordant cousin pairs, discordant half-siblings and discordant siblings, those with ADHD had HRs for DUD of 3.09, 2.10 and 2.38 respectively. Controlling for the number of ADHD registrations, ADHD patients with and without stimulant treatment were similarly associated with later DUD risk.
CONCLUSIONS: ADHD diagnosed before 15 years of age was strongly related to future risk for DUD. The magnitude of this association was modestly reduced in relative pairs discordant for ADHD, suggesting that the ADHD-DUD association is partly causal and partly a result of familial confounding. We found no evidence to suggest that this association resulted from stimulant treatment.

Entities:  

Keywords:  Swedish national cohort

Mesh:

Year:  2014        PMID: 25119068      PMCID: PMC4329095          DOI: 10.1017/S0033291714001986

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  36 in total

Review 1.  Quantitative and molecular genetics of ADHD.

Authors:  Philip Asherson; Hugh Gurling
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 2.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

Authors:  Guilherme Polanczyk; Maurício Silva de Lima; Bernardo Lessa Horta; Joseph Biederman; Luis Augusto Rohde
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

3.  The effects of childhood ADHD symptoms on early-onset substance use: a Swedish twin study.

Authors:  Zheng Chang; Paul Lichtenstein; Henrik Larsson
Journal:  J Abnorm Child Psychol       Date:  2012-04

Review 4.  Linking ADHD, impulsivity, and drug abuse: a neuropsychological perspective.

Authors:  Gonzalo P Urcelay; Jeffrey W Dalley
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 5.  Attention deficit hyperactivity disorder and substance use disorders.

Authors:  Claudia M Szobot; Oscar Bukstein
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-04

6.  Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD.

Authors:  Timothy E Wilens; Joel Adamson; Stephanie Sgambati; Julia Whitley; Alison Santry; Michael C Monuteaux; Joseph Biederman
Journal:  Am J Addict       Date:  2007

Review 7.  Childhood attention deficit hyperactivity disorder and the development of substance use disorders: valid concern or exaggeration?

Authors:  Alison Looby
Journal:  Addict Behav       Date:  2007-11-04       Impact factor: 3.913

8.  Twin study of the relationship between adolescent attention-deficit/hyperactivity disorder and adult alcohol dependence.

Authors:  Alexis C Edwards; Kenneth S Kendler
Journal:  J Stud Alcohol Drugs       Date:  2012-03       Impact factor: 2.582

Review 9.  Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.

Authors:  Stephen V Faraone; Timothy E Wilens
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

10.  Selective drop-out in longitudinal studies and non-biased prediction of behaviour disorders.

Authors:  Dieter Wolke; Andrea Waylen; Muthanna Samara; Colin Steer; Robert Goodman; Tamsin Ford; Koen Lamberts
Journal:  Br J Psychiatry       Date:  2009-09       Impact factor: 9.319

View more
  14 in total

1.  Associations between childhood ADHD, gender, and adolescent alcohol and marijuana involvement: A causally informative design.

Authors:  Irene J Elkins; Gretchen R B Saunders; Stephen M Malone; Margaret A Keyes; Matt McGue; William G Iacono
Journal:  Drug Alcohol Depend       Date:  2017-12-27       Impact factor: 4.492

2.  Cross-generational transmission from drug abuse in parents to attention-deficit/hyperactivity disorder in children.

Authors:  K S Kendler; H Ohlsson; K Sundquist; J Sundquist
Journal:  Psychol Med       Date:  2016-04       Impact factor: 7.723

3.  Increased Risk of Smoking in Female Adolescents Who Had Childhood ADHD.

Authors:  Irene J Elkins; Gretchen R B Saunders; Stephen M Malone; Margaret A Keyes; Diana R Samek; Matt McGue; William G Iacono
Journal:  Am J Psychiatry       Date:  2017-08-25       Impact factor: 18.112

4.  Childhood attention-deficit/hyperactivity disorder symptoms and the development of adolescent alcohol problems: A prospective, population-based study of Swedish twins.

Authors:  Patrick D Quinn; Erik Pettersson; Sebastian Lundström; Henrik Anckarsäter; Niklas Långström; Clara Hellner Gumpert; Henrik Larsson; Paul Lichtenstein; Brian M D'Onofrio
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-12-30       Impact factor: 3.568

5.  Childhood ADHD Symptoms and Future Illicit Drug Use: The Role of Adolescent Cigarette Use.

Authors:  Chien-Ti Lee; Francis J McClernon; Scott H Kollins; Bernard F Fuemmeler
Journal:  J Pediatr Psychol       Date:  2018-03-01

6.  ADHD Medication and Substance-Related Problems.

Authors:  Patrick D Quinn; Zheng Chang; Kwan Hur; Robert D Gibbons; Benjamin B Lahey; Martin E Rickert; Arvid Sjölander; Paul Lichtenstein; Henrik Larsson; Brian M D'Onofrio
Journal:  Am J Psychiatry       Date:  2017-06-29       Impact factor: 18.112

7.  Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis.

Authors:  Amy M Yule; MaryKate Martelon; Stephen V Faraone; Nicholas Carrellas; Timothy E Wilens; Joseph Biederman
Journal:  J Psychiatr Res       Date:  2016-10-22       Impact factor: 4.791

8.  Disrupted Attention to Other's Eyes is Linked to Symptoms of ADHD in Childhood.

Authors:  Matilda A Frick; Karin C Brocki; Linda Halldner Henriksson; Johan Lundin Kleberg
Journal:  Child Psychiatry Hum Dev       Date:  2022-01-17

9.  ADHD symptoms in non-treatment seeking young adults: relationship with other forms of impulsivity.

Authors:  Samuel R Chamberlain; Konstantinos Ioannidis; Eric W Leppink; Faiza Niaz; Sarah A Redden; Jon E Grant
Journal:  CNS Spectr       Date:  2016-09-29       Impact factor: 3.790

Review 10.  The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.

Authors:  Stephen V Faraone; Tobias Banaschewski; David Coghill; Yi Zheng; Joseph Biederman; Mark A Bellgrove; Jeffrey H Newcorn; Martin Gignac; Nouf M Al Saud; Iris Manor; Luis Augusto Rohde; Li Yang; Samuele Cortese; Doron Almagor; Mark A Stein; Turki H Albatti; Haya F Aljoudi; Mohammed M J Alqahtani; Philip Asherson; Lukoye Atwoli; Sven Bölte; Jan K Buitelaar; Cleo L Crunelle; David Daley; Søren Dalsgaard; Manfred Döpfner; Stacey Espinet; Michael Fitzgerald; Barbara Franke; Manfred Gerlach; Jan Haavik; Catharina A Hartman; Cynthia M Hartung; Stephen P Hinshaw; Pieter J Hoekstra; Chris Hollis; Scott H Kollins; J J Sandra Kooij; Jonna Kuntsi; Henrik Larsson; Tingyu Li; Jing Liu; Eugene Merzon; Gregory Mattingly; Paulo Mattos; Suzanne McCarthy; Amori Yee Mikami; Brooke S G Molina; Joel T Nigg; Diane Purper-Ouakil; Olayinka O Omigbodun; Guilherme V Polanczyk; Yehuda Pollak; Alison S Poulton; Ravi Philip Rajkumar; Andrew Reding; Andreas Reif; Katya Rubia; Julia Rucklidge; Marcel Romanos; J Antoni Ramos-Quiroga; Arnt Schellekens; Anouk Scheres; Renata Schoeman; Julie B Schweitzer; Henal Shah; Mary V Solanto; Edmund Sonuga-Barke; César Soutullo; Hans-Christoph Steinhausen; James M Swanson; Anita Thapar; Gail Tripp; Geurt van de Glind; Wim van den Brink; Saskia Van der Oord; Andre Venter; Benedetto Vitiello; Susanne Walitza; Yufeng Wang
Journal:  Neurosci Biobehav Rev       Date:  2021-02-04       Impact factor: 9.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.